GALWAY – November 03, 2026 -- Medtronic's Symplicity Spyral renal denervation (RDN) system cut office systolic blood pressure by 18.2 mmHg at six months in the SPYRAL AFFIRM post-approval study, with no increase in antihypertensive medication. The company also received U.S. FDA approval to update the device's labeling with additional clinical data.

MILWAUKEE – October 28, 2026 -- ManpowerGroup (NYSE: MAN) has elected Lidia Fonseca, Pfizer's former Executive Vice President and Chief Digital and Technology Officer, to its Board of Directors, effective November 1, 2026.

TAIPEI – October 28, 2026 -- The 2026 Global Health and Welfare Forum brings together 43 speakers and moderators from 11 markets on Oct. 19–20 to test how AI, interoperable health data and precision medicine can move from research into hospitals, pharmaceutical manufacturing, medical-device companies and care networks. The program runs under the theme "The Future of Global Care: Achieving Trust-Centric Digital Health."

Boston – October 17, 2026 -- The MedTech Conference (#MTC26) in Boston this October will host its first dedicated gathering for chief medical officers, open to CMOs at AdvaMed member companies, according to Bobby Patrick, AdvaMed's SVP of Government Affairs.

Galway – October 07, 2026 -- Medtronic plc has fixed the final exchange ratio for its split-off of MiniMed Group, Inc. at 4.5939 shares of MiniMed common stock for every Medtronic ordinary share tendered and accepted.

Delray Beach, Fla. – September 28, 2026 -- The global telehealth and telemedicine market is projected to grow from USD 118.8 billion in 2026 to USD 198.9 billion by 2031, expanding at a compound annual growth rate of 10.9%, according to a new report from MarketsandMarkets. A separate figure cited in the same report puts the 2025 market at USD 106.0 billion, underscoring the sector's rapid acceleration ahead of the forecast period.

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics and secure distribution rights for the SentireTM surgical robotic system across select ex-US markets where it has regulatory approval.

Hong Kong – September 7, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medical device giant distribution rights to the SentireTM surgical robot in markets outside the United States where the system holds regulatory clearance.